Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness

European Respiratory Journal

Volumn 49, Issue 5, 2017, Pages

  Johnson, Miriam J ^a   Yorke, Janelle ^b   Hansen Flaschen, John ^c   Lansing, Robert ^d   Ekström, Magnus ^e   Similowski, Thomas ^f   Currow, David C ^a,g  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e LUND UNIVERSITY   (Sweden)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONSENSUS; DELPHI STUDY; DYSPNEA; EUROPE; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HOSPITAL; HUMAN; INTERNATIONAL COOPERATION; ORGANIZATION; PROCEDURES; PULMONOLOGY; QUESTIONNAIRE; STANDARDS; SYNDROME; THEORETICAL MODEL; UNITED STATES;

CONGRESSES AS TOPIC; CONSENSUS; DELPHI TECHNIQUE; DYSPNEA; EUROPE; EVIDENCE-BASED MEDICINE; HEALTH POLICY; HOSPITALS; HUMANS; INTERNATIONAL COOPERATION; MODELS, THEORETICAL; PULMONARY MEDICINE; SURVEYS AND QUESTIONNAIRES; SYNDROME; UNITED STATES;

EID: 85021830016     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02277-2016     Document Type: Article

References (42)

1. Currow DC, Plummer JL, Crockett A, et al. A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage 2009; 38: 533–545.
2. Harstall C, Ospina M. How prevalent is chronic pain? Pain Clin Upd 2003; 11: 1–4.
3. Addison RG. Chronic pain syndrome. Am J Med 1984; 77: 54–58.
4. Harper D. Online etymology dictionary. www.etymonline.com Date last accessed: November 13, 2016.
5. Pratter MR, Abouzgheib W, Akers S, et al. An algorithmic approach to chronic dyspnea. Respir Med 2011; 105: 1014–1021.
6. Currow DC, Smith J, Davidson PM, et al. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage 2010; 39: 680–690.
7. Ahmadi Z, Lundstrom S, Janson C, et al. End-of-life care in oxygen-dependent COPD and cancer: a national population-based study. Eur Respir J 2015; 46: 1190–1193.
8. Booth S, Silvester S, Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care 2003; 1: 337–344.
9. Disler RT, Green A, Luckett T, et al. Experience of advanced chronic obstructive pulmonary disease: metasynthesis of qualitative research. J Pain Symptom Manage 2014; 48: 1182–1199.
10. Gysels M, Higginson IJ. Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness. J Pain Symptom Manage 2008; 36: 451–460.
11. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434–1440.
12. Smith A, Currow DC, Abernethy AP, et al. Prevalence and outcomes of breathlessness in older adults: a national population study. J Am Geriatr Soc 2016; 64: 2035–2041.
13. Hammond EC. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health Nations Health 1964; 54: 11–23.
14. Waller K, Kaprio J, Kujala UM. Dyspnea and all-cause mortality: 28-yr follow-up study among adult twins. Med Sci Sports Exerc 2014; 46: 1538–1545.
15. Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report 2010; 1–31.
16. Langlo NM, Orvik AB, Dale J, et al. The acute sick and injured patients: an overview of the emergency department patient population at a Norwegian University Hospital Emergency Department. Eur J Emerg Med 2014; 21: 175–180.
17. Currow DC, Abernethy AP, Allcroft P, et al. The need to research refractory breathlessness. Eur Respir J 2016; 47: 342–343.
18. Currow DC, Abernethy AP, Ko DN. The active identification and management of chronic refractory breathlessness is a human right. Thorax 2014; 69: 393–394.
19. Booth S, Bausewein C, Higginson I, et al. Pharmacological treatment of refractory breathlessness. Expert Rev Respir Med 2009; 3: 21–36.
20. Johnson MJ, Bland JM, Oxberry SG, et al. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage 2013; 46: 957–963.
21. Ekstrom M, Nilsson F, Abernethy AA, et al. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc 2015; 12: 1079–1092.
22. Ekstrom MP, Abernethy AP, Currow DC. The management of chronic breathlessness in patients with advanced and terminal illness. BMJ 2015; 349: g7617.
23. Higginson IJ, Bausewein C, Reilly CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med 2014; 2: 979–987.
24. Johnson MJ, Currow DC. Chronic refractory breathlessness is a distinct clinical syndrome. Curr Opin Support Palliat Care 2015; 9: 203–205.
25. Hsu C, Sandford BB. The Delphi technique: making sense of consensus. Pract Assess Res Eval 2007; 12: 1–8.
26. WHO. International Classification of Functioning, Disability and Health (ICF): Towards a Common Language for Functioning, Disability and Health. Geneva, World Health Organization, 2002.
27. Johnson MJ, Simpson MI, Currow DC, et al. Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: a feasibility pilot. BMJ Open 2015; 5: e007535.
28. Herigstad M, Hayen A, Evans E, et al. Dyspnea-related cues engage the prefrontal cortex: evidence from functional brain imaging in COPD. Chest 2015; 148: 953–961.
29. Jolley CJ, Luo YM, Steier J, et al. Neural respiratory drive in healthy subjects and in COPD. Eur Respir J 2009; 33: 289–297.
30. Jolley CJ, Luo YM, Steier J, et al. Neural respiratory drive and breathlessness in COPD. Eur Respir J 2015; 45: 355–364.
31. Karras DJ, Sammon ME, Terregino CA, et al. Clinically meaningful changes in quantitative measures of asthma severity. Acad Emerg Med 2000; 7: 327–334.
32. Bennett MI, Flemming K, Closs SJ. Education in cancer pain management. Curr Opin Support Palliat Care 2011; 5: 20–24.
33. Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage 2011; 42: 388–399.
34. Ekstrom MP, Bornefalk-Hermansson A, Abernethy AP, et al. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ 2014; 348: g445.
35. Farquhar MC, Prevost A, McCrone P, et al. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med 2014; 12: 194.
36. Johnson MJ, Kanaan M, Richardson G, et al. A randomised controlled trial of three or one breathing technique training sessions for breathlessness in people with malignant lung disease. BMC Med 2015; 13: 213.
37. Livermore N, Dimitri A, Sharpe L, et al. Cognitive behaviour therapy reduces dyspnoea ratings in patients with chronic obstructive pulmonary disease (COPD). Respir Physiol Neurobiol 2015; 216: 35–42.
38. Mularski RA, Reinke LF, Carrieri-Kohlman V, et al. An official American Thoracic Society workshop report: assessment and palliative management of dyspnea crisis. Ann Am Thorac Soc 2013; 10: S98–S106.
39. Task Force on Taxonomy of the International Association for the Study of Pain. Classification of Chronic Pain. Descriptions of Chronic Pain Syndromes And Definitions Of Pain Terms. 2nd Edition. Seattle, IASP Press, 1994.
40. Vozoris NT, Wang X, Fischer HD, et al. Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Br J Clin Pharmacol 2016; 81: 161–170.
41. Rocker GM, Sinuff T, Horton R, et al. Advanced chronic obstructive pulmonary disease: innovative approaches to palliation. J Palliat Med 2007; 10: 783–797.
42. Schmidt M, Banzett RB, Raux M, et al. Unrecognized suffering in the ICU: addressing dyspnea in mechanically ventilated patients. Intensive Care Med 2014; 40: 1–10.